NCT06120283 2026-04-15BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid TumorsBeOne MedicinesPhase 1 Recruiting399 enrolled
NCT04553133 2026-04-13PF-07104091 as a Single Agent and in Combination TherapyPfizerPhase 2 Active not recruiting157 enrolled
NCT06625775 2026-04-13Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsTheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Phase 1 Recruiting392 enrolled